Home›Stocks›LPCN

LPCN — structural market context

Lipocine Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 23. Each line shows the earlier value, the later value and their dates.

Price

Close $1.44 (Oct 23) vs $1.46 (Oct 22): −1.37%.

Volume

0.04× its 20-session average (5.6M) on Oct 23.

Includes pre- and post-market trading.

Short interest

Short interest 98K shares (settlement Sep 30) vs 99K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 4 days with fails, largest 23 shares on Sep 21.

Previous file (settlements Sep 1–Sep 14, published Sep 30): no fails listed.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

LPCN events and their magnitude

Latest SEC filing in the event study

8-K 8.01 · Other events · filed 2026-10-20 · View on sec.gov ↗

…

Open the Event Study →

LPCN short interest & days to cover

SHARES SHORT
98K
% OF FLOAT
1.2%
DAYS TO COVER
2.3
CHANGE VS PRIOR
-1.6%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (24d ago)

LPCN fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-29 · 25d1$2.09
2026-09-24 · 30d1$2.12
2026-09-22 · 32d1$2.24

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

LPCN insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 3 purchases · 0 sales

InsiderTypeSharesValueFiled
Higuchi John W. · directorPurchase (P)16K$36K2026-10-01
Higuchi John W. · directorPurchase (P)9K$19K2026-10-01
Higuchi John W. · directorPurchase (P)13K$27K2026-09-30

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

LPCN analyst ratings

FirmActionRatingPublished
Cantor FitzgeraldholdOverweight2026-09-22
H.C. Wainwrightprice_target—2026-09-22
H.C. WainwrightholdNeutral2026-09-21

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is LPCN's short interest?
As of the FINRA settlement date 2026-09-30, LPCN had 98K shares sold short — 1.2% of its float, with 2.3 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying LPCN?
In the last 12 months of SEC Form 4 filings, LPCN recorded 3 insider purchases and 0 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about LPCN?
The most recent action: Cantor Fitzgerald hold to Overweight on 2026-09-22. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell LPCN?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with L

LIFE · Ethos Technologies Inc. ClassLMT · Lockheed Martin Corp.LNG · Cheniere Energy IncLOAR · Loar Holdings Inc.LPX · Louisiana-Pacific Corp.LUNR · Intuitive Machines, Inc. ClassAll L →

LPCN: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.